<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02708433</url>
  </required_header>
  <id_info>
    <org_study_id>16-0068a</org_study_id>
    <nct_id>NCT02708433</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine</brief_title>
  <official_title>Pilot Study: Comparison of Buffered 1% vs. Non-Buffered 2% Lidocaine Used in Dental and Oral Surgical Procedures: Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anecdotal data suggest that the buffered form of the local anesthetic is more potent at equal
      dosages, and a lower dosage of the drug might be used with an effect equal to higher dosage
      not buffered. Clinical data are needed to confirm these anecdotal data. No data exist
      comparing buffered local anesthetics at lower drug concentrations to current dosages commonly
      used in dental and oral surgical procedures
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aims:

      Compare clinical depths of pulpal anesthesia (cold, Electronic Pulp Test) for mandibular
      molar, and canine teeth at 30 minute intervals post injection for mandibular block anesthesia
      with buffered 1% lidocaine with 1/100,000 epinephrine as compared to non-buffered 2%
      lidocaine with 1/100,000 epinephrine.

      Hypotheses:

      No differences exist in anesthetic depth for pulpal anesthesia after intraoral injection for
      mandibular block anesthesia between buffered 1% lidocaine with 1/100,000 epinephrine as
      compared to non-buffered 2% lidocaine with 1/100,000 epinephrine.

      Study Time Frame: 6 months Month One: Recruit 24 volunteers as subjects. Prepare case-books.
      Months Two-Three: Clinical Study, Months Four-Five: Analyze data Month Six: Prepare
      Abstracts, Papers Methods: Blinded, Randomized Clinical Design Recruit subjects with
      Institutional Review Board approved consent at UNC Subjects will serve as their own controls
      in a cross-over AB/BA study design which is uniform within sequences, uniform within periods,
      and balanced Randomized subjects to be injected orally for mandibular block (inferior
      alveolar, lingual, buccal nerves) alternatively with 4cc of buffered 1% lidocaine with
      1/100,000 epinephrine and 4cc non-buffered of 2% lidocaine with 1/100,000 epinephrine.

      Assessment: pre, and post-anesthetic administration for pulpal anesthesia with cold,
      Electronic Pulp Test: Mandibular molar, canine at 30 minute intervals Inclusion Criteria: Age
      18-30 years, American Society Anesthesiologists (ASA) I Exclusion Criteria Allergy to
      lidocaine class of anesthetic drugs, Local anesthetic drug past week Current symptoms teeth
      or oral mucosa. SAS will be used for database management and statistical analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Time to Pulpal Response After Mandibular Molar Anesthesia</measure>
    <time_frame>Every 30 minutes up to 120 minutes total</time_frame>
    <description>Subject's Mandibular first molar teeth tested before anesthetic and every 30 minutes after for response to Cold and Electric Pulp Test as reported by subjects as a &quot;yes&quot; or &quot;no.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Time to Pulpal Response After Mandibular Canine Anesthesia</measure>
    <time_frame>Every 30 minutes up to 120 minutes total</time_frame>
    <description>Subject's Mandibular canine teeth will be tested before anesthetic and every 30 minutes after for response to Cold and Electronic Pulp Test for presence of anesthesia as reported by participants &quot;yes&quot; or &quot;no.&quot;</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Buffered 1% lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In week one each subject would receive either anesthetic (Buffered 1% lidocaine with 1/100,000 Epinephrine) or (Non-Buffered 2% lidocaine with 1/100,000 Epinephrine) to block the inferior alveolar, lingual, buccal nerves.
In week two the alternate anesthetic would be administered.
Mandibular molar and canine tested for pulpal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Buffered lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In week two each subject would receive the alternate anesthetic (Buffered 1% lidocaine with 1/100,000 Epinephrine) or (Non-Buffered 2% lidocaine with 1/100,000 Epinephrine) to block the inferior alveolar, lingual, buccal nerves.
Mandibular molar and canine tested for pulpal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Lidocaine</description>
    <arm_group_label>Buffered 1% lidocaine</arm_group_label>
    <arm_group_label>Non-Buffered lidocaine</arm_group_label>
    <other_name>xylocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-30 years, ASA I

        Exclusion Criteria:

          -  Allergy to lidocaine class of anesthetic drugs Local anesthetic drug use in past week
             Current symptoms teeth or oral mucosa
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond P White, Jr., DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNC Dept Oral and Maxillofacial Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UNC School of Dentistry</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>March 3, 2016</study_first_submitted>
  <study_first_submitted_qc>March 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2016</study_first_posted>
  <results_first_submitted>July 27, 2018</results_first_submitted>
  <results_first_submitted_qc>August 31, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 4, 2018</results_first_posted>
  <last_update_submitted>August 31, 2018</last_update_submitted>
  <last_update_submitted_qc>August 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lidocaine, jaw</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plans</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 1, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/33/NCT02708433/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Buffered 1% Lidocaine, Then Non-buffered 2% Lidocaine</title>
          <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Buffered 1% Lidocaine followed by a 1-week washout, then Non-buffered 2% Lidocaine.</description>
        </group>
        <group group_id="P2">
          <title>Non-Buffered 2% Lidocaine, Then Buffered 1% Lidocaine</title>
          <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Non-Buffered 2% Lidocaine followed by a 1-week washout, then Buffered 1% Lidocaine.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (Visit 1)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (at Least 1 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (Visit 2)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>All participants who were randomized to received either Buffered 1% Lidocaine or Non-buffered 2% Lidocaine</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Time to Pulpal Response After Mandibular Molar Anesthesia</title>
        <description>Subject's Mandibular first molar teeth tested before anesthetic and every 30 minutes after for response to Cold and Electric Pulp Test as reported by subjects as a &quot;yes&quot; or &quot;no.&quot;</description>
        <time_frame>Every 30 minutes up to 120 minutes total</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Buffered 1% Lidocaine, Then Non-buffered 2% Lidocaine</title>
            <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Buffered 1% Lidocaine followed by a 1-week washout, then Non-buffered 2% Lidocaine.</description>
          </group>
          <group group_id="O2">
            <title>Non-Buffered 2% Lidocaine, Then Buffered 1% Lidocaine</title>
            <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Non-Buffered 2% Lidocaine followed by a 1-week washout, then Buffered 1% Lidocaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time to Pulpal Response After Mandibular Molar Anesthesia</title>
          <description>Subject's Mandibular first molar teeth tested before anesthetic and every 30 minutes after for response to Cold and Electric Pulp Test as reported by subjects as a &quot;yes&quot; or &quot;no.&quot;</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99" spread="49"/>
                    <measurement group_id="O2" value="98" spread="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.74</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>49</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.49</ci_lower_limit>
            <ci_upper_limit>0.57</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Time to Pulpal Response After Mandibular Canine Anesthesia</title>
        <description>Subject's Mandibular canine teeth will be tested before anesthetic and every 30 minutes after for response to Cold and Electronic Pulp Test for presence of anesthesia as reported by participants &quot;yes&quot; or &quot;no.&quot;</description>
        <time_frame>Every 30 minutes up to 120 minutes total</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Buffered 1% Lidocaine, Then Non-buffered 2% Lidocaine</title>
            <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Buffered 1% Lidocaine followed by a 1-week washout, then Non-buffered 2% Lidocaine.</description>
          </group>
          <group group_id="O2">
            <title>Non-Buffered 2% Lidocaine, Then Buffered 1% Lidocaine</title>
            <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Non-Buffered 2% Lidocaine followed by a 1-week washout, then Buffered 1% Lidocaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Time to Pulpal Response After Mandibular Canine Anesthesia</title>
          <description>Subject's Mandibular canine teeth will be tested before anesthetic and every 30 minutes after for response to Cold and Electronic Pulp Test for presence of anesthesia as reported by participants &quot;yes&quot; or &quot;no.&quot;</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" spread="48"/>
                    <measurement group_id="O2" value="85" spread="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>48</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.89</ci_lower_limit>
            <ci_upper_limit>0.52</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events collected for 24 hours after active component of the trial</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Buffered 1% Lidocaine</title>
          <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Buffered 1% Lidocaine followed by a 1-week washout, then Non-buffered 2% Lidocaine.</description>
        </group>
        <group group_id="E2">
          <title>Non-Buffered 2% Lidocaine</title>
          <description>At each treatment visit, participants were injected orally for mandibular block (inferior alveolar, lingual, buccal nerves).
For this arm, participants first received Non-Buffered 2% Lidocaine followed by a 1-week washout, then Buffered 1% Lidocaine.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Raymond P. White, Jr. DDS, PhD</name_or_title>
      <organization>University of North Carolina at Chapel Hill</organization>
      <phone>919-537-3944</phone>
      <email>ray_white@unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

